Back
CRISPR Therapeutics AG Stock Price Chart
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
40
CRSP
CRISPR Therapeutics AG
Last Price:
$56.77
Seasonality Move:
11.08%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight buying pressure.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.69 | Buy |
| 20-day SMA: | 53.3 | Buy |
| 50-day SMA: | 61.53 | Sell |
| 200-day SMA: | 50.54 | Buy |
| 8-day EMA: | 54.29 | Buy |
| 20-day EMA: | 54.91 | Buy |
| 50-day EMA: | 56.35 | Buy |
| 200-day EMA: | 35.36 | Buy |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.62 | Sell |
| Relative Strength Index (14 RSI): | 54.97 | Buy |
| Chaikin Money Flow: | 1067032 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.02 - 58.28) | Buy |
| Bollinger Bands (100): | (52.92 - 66.22) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 58.18 while CRSP 8-day simple moving average is 53.69, which is a Buy signal.
-
The stock price of CRSP is 58.18 while CRISPR Therapeutics AG 20-day SMA is 53.30, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day simple moving average is 61.53 while CRSP share price is 58.18, making it a Sell technically.
-
CRSP stock price is 58.18 and CRISPR Therapeutics AG 200-day simple moving average is 50.54, creating a Buy signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
40
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $58.18. The Score for CRSP is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
5.5B
Price in USD:
58.18
Share Volume:
3.1M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
78.48
52-Week Low:
30.04
Sell
40
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 58.18 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 58.18 while CRSP 8-day exponential moving average is 54.29, which is a Buy signal.
-
The stock price of CRSP is 58.18 while CRISPR Therapeutics AG 20-day EMA is 54.91, which makes it a Buy.
-
CRISPR Therapeutics AG 50-day exponential moving average is 56.35 while CRSP share price is 58.18, making it a Buy technically.
-
CRSP stock price is 58.18 and CRISPR Therapeutics AG 200-day simple moving average is 35.36, creating a Buy signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is -1.62, suggesting CRISPR Therapeutics AG is a Sell
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 54.97, which suggest CRISPR Therapeutics AG is overbought
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (51.02 - 58.28), which suggest CRISPR Therapeutics AG is a Sell
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (52.92 - 66.22), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.